- Company Name
- X-Therma
- Company Description
- •Breakthrough technology for cell, tissue ($8.8Bn) and organ preservation ($10Bn)
•Enables all regenerative medicine by solving the fundamental legacy problem of preservation
•IP -Global protection with issued patents-composition of matter
•$11M in government contracts and grants; $10M in-kind and access to $150M facility
•Venture-backed company (Series A press release)
•FDA Breakthrough Designation
•Cell product XT-Thrive®in revenue now (Phase appropriate GMP to full GMP)
•Organ product XT-ViVo®+ TimeSeal®buy-in from large transplant centers, OPOs and bipartisan congressional support
•Strong DoD contract interests (DPSI, BARDA, MRMC, ARMI)
•Global team–San Francisco Bay Area (HQ) and Innsbruck, Austria (1stsubsidiary)
- Website
-
—
- Industry Type
-
Other
- Incoming Channel
- —